Singclean Medical will participate in the Aesthetic & Anti-Aging Medicine World Congress (AMWC) 2026, taking place from March 26 to 28, 2026, at the Grimaldi Forum in Monaco. As one of the most influential global events in aesthetic medicine, AMWC gathers leading physicians, researchers, and industry pioneers to exchange insights on cutting-edge technologies and emerging trends.

At this year’s congress, Singclean Medical will welcome visitors at Booth H21 (Diaghilev Area), presenting its latest advancements in injectable and regenerative aesthetic solutions. The company continues to strengthen its global presence by delivering clinically driven, innovation-focused products tailored to evolving market demands.
Singclean’s featured portfolio will include a comprehensive range of aesthetic products, such as cross-linked hyaluronic acid (HA) fillers, PLLA-based biostimulators, and PDRN skincare solutions. These offerings are designed to address a wide spectrum of clinical applications, from facial contouring and volumization to skin regeneration and post-procedure recovery.
Among these, regenerative aesthetics remains a key highlight. Singclean’s PLLA-based biostimulator products are engineered to promote collagen neogenesis, supporting long-term tissue remodeling and natural-looking results. This category has gained significant traction worldwide, reflecting a growing shift toward treatments that combine immediate outcomes with sustained biological benefits.
In addition to product showcases, Singclean Medical will actively engage in professional exchanges throughout the congress, fostering collaboration with dermatologists, plastic surgeons, and distribution partners from across the globe. The company aims to further expand its international network while advancing localized market strategies in key regions.
With products already distributed in over 30 countries and regions, Singclean Medical continues to build a strong reputation for quality, safety, and innovation. Its participation in AMWC 2026 underscores the company’s commitment to contributing to the global aesthetic medicine landscape and supporting practitioners with reliable, high-performance solutions.
Looking ahead, Singclean Medical remains dedicated to continuous R&D investment and clinical validation, striving to deliver next-generation aesthetic technologies that meet both physician expectations and patient needs.
-
singclean | 2026-02-25
Renowned International Medical Expert Prof. Osama Shawki Visits Singclean, Exploring New Global Collaboration in Anti-Adhesion SolutionsHangzhou, China — November 2, 2024 — Prof. Osama Shawki, a renowned international expert in obstetrics and gynecology, Professor at Cairo University, and globally recognized medical KOL with millions of views, visited the headquarters of Singclean Medical. -
singclean | 2026-02-25
A Powerful Alliance for Premium Aesthetics | Singclean Medical x HTL Biotechnology (France)On October 20, 2026, a four-member delegation from French HTL Biotechnology visited Singclean Medical for an exchange and factory tour. This significant meeting aimed to deepen the strategic cooperation between the two parties in the application of premium hyaluronic acid (HA) raw materials and global brand promotion, jointly exploring new growth opportunities for premium injectable HA in the global market. -
singclean | 2026-02-25
Singclean Medical: 15 Years of Chongyang Care — 2026 Event Reaches 337 Elderly Residents Across 6 CommunitiesIn 2011, during the Chongyang Festival—a traditional Chinese occasion dedicated to respecting the elderly—Singclean Medical first entered local communities to deliver cooking oil, rice, and other daily necessities to senior residents. That simple act of care has never stopped. For 15 consecutive years, the company has continued this tradition, bringing warmth and support to the elderly every autumn.